Letter by Smolderen and Pelle regarding article, "Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial"

Circulation. 2010 Aug 31;122(9):e445; author reply e446. doi: 10.1161/CIRCULATIONAHA.110.942086.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Benzazepines / therapeutic use*
  • Cardiovascular Diseases / epidemiology*
  • Depression / epidemiology*
  • Humans
  • Nicotinic Agonists / therapeutic use
  • Patient Selection*
  • Quinoxalines / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Smoking / epidemiology
  • Smoking Cessation / methods*
  • Varenicline

Substances

  • Benzazepines
  • Nicotinic Agonists
  • Quinoxalines
  • Varenicline